Oncoinvent ASA (ONCIN)
Oslo Stock Exchange · Norway · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 67.00 |
|---|---|
| 52-week range | 40.10 – 144.00 |
| Return, 1 month / 3 months | −39.1% / −23.9% |
| Return, 1 year / 3 years | −9.9% / −95.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 30 |
| Volatility (1 year) | 75.7% |
| Worst drawdown (1 year) | -52.7% |
| Average daily value traded | 3.67M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Oncoinvent ASA (ONCIN) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 67.00 on 22 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 173 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.9% and over the last three months it fell 23.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.7% | ||
| From 52-week high | -52.7% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -23.9% | ||
| 6-month return | 35.4% | ||
| 12-month return, skipping the last month | 48.0% | ||
| Stability (higher is calmer) | 15 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 75.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -52.7% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.67M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −1.5% |
|---|---|
| 1 month | −39.1% |
| 3 months | −23.9% |
| 6 months | +35.4% |
| 1 year | −9.9% |
| 3 years | −95.2% |
| 5 years | −99.9% |
Signals
| 50-day / 200-day average | 90.79 / 61.65 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.11 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.